LifeMD, Inc. — Director's Dealing 2023

Jun 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-20

Reporting Person: FEBBO WILLIAM J (Director, Consultant)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-20	Common Stock	A	75000	—	Acquired	450000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-20	Employee Stock Option (Right to Buy)	$3.37	A	37500	Acquired	2028-06-20	Common Stock (37500)	Direct

Footnotes

F1: The grant of restricted stock shares vests 37,500 shares immediately and the remaining 37,500 shares on the second anniversary of the date of grant.

F2: The options vest on the second anniversary of the date of grant.